Literature DB >> 1703179

Dextran-conjugated anti-Ig antibodies as a model for T cell-independent type 2 antigen-mediated stimulation of Ig secretion in vitro. I. Lymphokine dependence.

L M Peçanha1, C M Snapper, F D Finkelman, J J Mond.   

Abstract

We have previously demonstrated that dextran-conjugated anti-IgD antibodies (anti-delta-dex) stimulate high levels of B cell proliferation at concentrations that are 1000-fold lower than that required by unconjugated anti-Ig. We now show that anti-delta-dex may provide a suitable model to study Ig secretion stimulated by soluble T cell-independent type 2 Ag exemplified by TNP-Ficoll. Thus, both TNP-Ficoll and anti-delta-dex stimulate low to undetectable levels of Ig secretion when cultured with resting B cells. Addition of IL-5 or IL-2 stimulated enhanced anti-TNP responses in the presence of TNP-Ficoll, or induced polyclonal Ig secretion in the presence of anti-delta-dex. Both TNP-Ficoll and anti-delta-dex conjugates stimulated Ig production by Percoll-separated low density (partially activated) B cells in the absence of added lymphokines. These findings point to the similarities in the activation requirements of TNP-Ficoll and anti-delta-dex and suggest that dextran-anti-Ig conjugates, which can induce B cell activation irrespective of Ag specificity, may provide a useful model for studying various parameters that characterize the responses to soluble TI type 2 Ag.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1703179

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

Review 1.  T lymphocyte dependence of the antibody response to 'T lymphocyte independent type 2' antigens.

Authors:  A Jeurissen; J L Ceuppens; X Bossuyt
Journal:  Immunology       Date:  2004-01       Impact factor: 7.397

Review 2.  Immunological risk of injectable drug delivery systems.

Authors:  Wim Jiskoot; Rianne M F van Schie; Myrra G Carstens; Huub Schellekens
Journal:  Pharm Res       Date:  2009-02-27       Impact factor: 4.200

3.  UV photodegradation of murine growth hormone: chemical analysis and immunogenicity consequences.

Authors:  Amber Haynes Fradkin; Olivier Mozziconacci; Christian Schöneich; John F Carpenter; Theodore W Randolph
Journal:  Eur J Pharm Biopharm       Date:  2014-04-20       Impact factor: 5.571

Review 4.  Antibody repertoires in infants and adults: effects of T-independent and T-dependent immunizations.

Authors:  E E Adderson
Journal:  Springer Semin Immunopathol       Date:  2001-12

5.  Up-regulation of CD40 ligand and induction of a Th2 response in children immunized with pneumococcal polysaccharide vaccines.

Authors:  L E Leiva; B Butler; J Hempe; A P Ortigas; R U Sorensen
Journal:  Clin Diagn Lab Immunol       Date:  2001-03

6.  Contact dependent suppression of CD4 T cell activation and proliferation by B cells activated through IgD cross-linking.

Authors:  Lorena Preciado-Llanes; James B Wing; Rachel A Foster; Jennifer Carlring; Andrew Lees; Robert C Read; Andrew W Heath
Journal:  Immunology       Date:  2014-09-20       Impact factor: 7.397

7.  Neisserial porins may provide critical second signals to polysaccharide-activated murine B cells for induction of immunoglobulin secretion.

Authors:  C M Snapper; F R Rosas; M R Kehry; J J Mond; L M Wetzler
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

8.  Humoral immune responses in CD40 ligand-deficient mice.

Authors:  B R Renshaw; W C Fanslow; R J Armitage; K A Campbell; D Liggitt; B Wright; B L Davison; C R Maliszewski
Journal:  J Exp Med       Date:  1994-11-01       Impact factor: 14.307

9.  Evidence of a functional B-cell immunodeficiency in adults who experience serogroup C meningococcal disease.

Authors:  Rachel A Foster; Jennifer Carlring; Michael W McKendrick; Andrew Lees; Ray Borrow; Robert C Read; Andrew W Heath
Journal:  Clin Vaccine Immunol       Date:  2009-03-11

Review 10.  Strategies to overcome the ABO barrier in kidney transplantation.

Authors:  Georg A Böhmig; Andreas M Farkas; Farsad Eskandary; Thomas Wekerle
Journal:  Nat Rev Nephrol       Date:  2015-09-01       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.